Literature DB >> 6294323

mlt Mutants of polyoma virus.

D Ding, S M Dilworth, B E Griffin.   

Abstract

New mlt deletion mutants of polyoma virus were isolated, and their abilities to produce a lytic response in mouse cells or to transform rat cells were assessed. Their properties were analyzed in terms of the sequences deleted and their effects upon the structure and functions of the viral middle and large T-antigens.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6294323      PMCID: PMC256370     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  14 in total

1.  New classes of viable deletion mutants in the early region of polyoma virus.

Authors:  B E Griffin; C Maddock
Journal:  J Virol       Date:  1979-09       Impact factor: 5.103

2.  Polyoma virus-specific 55K protein isolated from plasma membrane of productively infected cells is virus-coded and important for cell transformation.

Authors:  Y Ito
Journal:  Virology       Date:  1979-10-15       Impact factor: 3.616

3.  Construction and analysis of viable deletion mutants of polyoma virus.

Authors:  G Magnusson; P Berg
Journal:  J Virol       Date:  1979-11       Impact factor: 5.103

4.  State of the viral DNA in rat cells transformed by polyoma virus. I. Virus rescue and the presence of nonintergrated viral DNA molecules.

Authors:  I Prasad; D Zouzias; C Basilico
Journal:  J Virol       Date:  1976-05       Impact factor: 5.103

5.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

6.  Viable deletion mutant in the medium and large T-antigen-coding sequences of the polyoma virus genome.

Authors:  M M Bendig; T Thomas; W R Folk
Journal:  J Virol       Date:  1980-03       Impact factor: 5.103

7.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

8.  DNA sequences of polyoma virus early deletion mutants.

Authors:  N Smolar; B E Griffin
Journal:  J Virol       Date:  1981-06       Impact factor: 5.103

9.  Middle T antigen as primary inducer of full expression of the phenotype of transformation by polyoma virus.

Authors:  Y Ito; N Spurr; B E Griffin
Journal:  J Virol       Date:  1980-07       Impact factor: 5.103

10.  Coding potential and regulatory signals of the polyoma virus genome.

Authors:  E Soeda; J R Arrand; N Smolar; J E Walsh; B E Griffin
Journal:  Nature       Date:  1980-01-31       Impact factor: 49.962

View more
  6 in total

1.  Small and middle T antigens contribute to lytic and abortive polyomavirus infection.

Authors:  H Türler; C Salomon
Journal:  J Virol       Date:  1985-02       Impact factor: 5.103

2.  Significance of the gastrin homology and surrounding sequences in polyomavirus middle T antigen for cell transformation.

Authors:  K L Clark; W R Folk
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

3.  The major site of tyrosine phosphorylation in polyomavirus middle T antigen is not required for transformation.

Authors:  A M Mes-Masson; B Schaffhausen; J A Hassell
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

4.  Characterization of viable mutants of polyomavirus cold sensitive for maintenance of cell transformation.

Authors:  D Templeton; W Eckhart
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

5.  Construction and expression of a recombinant DNA gene encoding a polyomavirus middle-size tumor antigen with the carboxyl terminus of the vesicular stomatitis virus glycoprotein G.

Authors:  D Templeton; A Voronova; W Eckhart
Journal:  Mol Cell Biol       Date:  1984-02       Impact factor: 4.272

6.  Antibodies against a nonapeptide of polyomavirus middle T antigen: cross-reaction with a cellular protein(s).

Authors:  Y Ito; Y Hamagishi; K Segawa; T Dalianis; E Appella; M Willingham
Journal:  J Virol       Date:  1983-12       Impact factor: 5.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.